In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Type

Type

Guidance programme

Showing 1 to 4 of 4

TitleTypeExpected publication date
Cladribine for treating relapsing multiple sclerosis [ID6263]Technology appraisal guidance
Evobrutinib for treating relapsing multiple sclerosis [ID6313]Technology appraisal guidanceTBC
Multiple sclerosis (relapsing, remitting, highly active) - natalizumab and Tyruko (natalizumab biosimilar) (after disease modifying therapy) [ID6369]Technology appraisal guidance
Ublituximab for treating relapsing multiple sclerosis [ID6350]Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All